Genetic silencing of NRF2 reduced TRPA1 expression in lung cancer cell lines, while it did not affect the expression levels of other TRP isoforms, such as TRPC3 and TRPV1 [29]. The gene discussed is NFE2L2; the disease is lung carcinoma.